Global Fabry Disease Market 2015-2019

  • Published on
    14-Jun-2015

  • View
    26

  • Download
    1

Embed Size (px)

DESCRIPTION

Global Fabry Disease Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Fabry Disease market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Complete Report Available @ http://www.reportsnreports.com/reports/314042-global-fabry-disease-market-2015-2019.html

Transcript

  • 1. Global Fabry Disease Market 2015-2019Published: November 2014Single User PDF: US$ 2500Corporate User PDF: US$ 3500Order this report by calling+1 888 391 5441 or Send an emailto sales@reportsandreports.comwith your contact details andquestions if any. ReportsnReports.com / Contact sales@reportsandreports.com 1

2. Global Fabry Disease Market 2015-2019Fabry disease is an inheritable lysosomal storage disease characterized by the excessive accumulationof globotriaosylceramide (GL-3) in lysosomes. It results from a deficiency of a-Gal and can result insymptoms such as fatigue, angiokeratoma, tinnitus, kidney failure, heart disorders, and nervoussystem problems. Fabry disease results from mutations in the galactosidase (GLA) gene, resulting indecreased activity or complete absence of a-Gal. Fabry disease resulting from the decreased activityof the enzyme is called later-onset Fabry disease. This form of the disease can effect both males andfemales. The symptoms of this disease typically appear during adulthood and usually focus on asingle organ. Fabry disease resulting from the complete absence of a-Gal results in a more severeform called classic Fabry disease. The classic form of the disease usually affects males. The diseasesymptoms usually starts in adolescence and include clouded eye lenses, skin lesions, pain, andreduced sweating. If untreated, the disease can lead to cardiac dysfunction, renal failure or stroke,often resulting in death during fourth or fifth decade of life.Analysts forecast the Global Fabry Disease market to grow at a CAGR of 18.08 percent over theperiod 2014-2019.Complete Report Available @ http://www.reportsnreports.com/reports/314042-global-fabry-disease-market-2015-2019.htmlOrder this report by calling +1 888 391 5441 or Send an email tosales@reportsandreports.com with your contact details and questions if any. ReportsnReports.com / Contact sales@reportsandreports.com 2 3. Global Fabry Disease Market 2015-2019Covered in this ReportThis report covers the present scenario and the growth prospects of the Global Fabry Disease marketfor the period 2015-2019. To calculate the market size, the report considers the revenue generatedfrom the sales of various innovator drugs available in the market for the treatment of fabry disease.Global Fabry Disease Market 2015-2019, has been prepared based on an in-depth market analysiswith inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions;it also covers the Global Fabry Disease market landscape and its growth prospects in the comingyears. The report includes a discussion of the key vendors operating in this market.Key RegionsAmericas APAC & EMEASingle User License Available US $ 2500 Order a copy of this report at @http://www.reportsnreports.com/Purchase.aspx?name=314042Key VendorsGenzyme, ShireOther Prominent VendorsAmicus Therapeutics, Green Cross Corporation, ISU Abxis, JCR Pharmaceuticals, Protalix ,iotherapeuticsOrder this report by calling +1 888 391 5441 or Send an email tosales@reportsandreports.com with your contact details and questions if any. ReportsnReports.com / Contact sales@reportsandreports.com 3 4. Global Fabry Disease Market 2015-2019Market DriverSpecial Provisions for Orphan DrugsMarket ChallengeLimited Patient PopulationMarket TrendRegulatory Assistance in Emerging CountriesKey Questions Answered in this ReportWhat will the market size be in 2018 and what will the growth rate be?What are the key market trends?What is driving this market?What are the challenges to market growth?Who are the key vendors in this market space?What are the market opportunities and threats faced by the key vendors?What are the strengths and weaknesses of the key vendors?Inquire for this report @http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=314042Order this report by calling +1 888 391 5441 or Send an email tosales@reportsandreports.com with your contact details and questions if any. ReportsnReports.com / Contact sales@reportsandreports.com 4 5. Global Fabry Disease Market 2015-2019Table of Contents01. Executive Summary02. List of Abbreviations03. Scope of the Report04. Market Research Methodology05. Disease Overview06. Introduction07. Market Landscape08. Market Segmentation by Cell Line Used for Manufacturing the Drug09. Geographical Segmentation10. Buying Criteria11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact17. Vendor Landscape 18. Pipeline Analysis 19. Fabry Registry 20. Key Vendor Analysis21. Other Reports in this SeriesInquire for Discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=314042Order this report by calling +1 888 391 5441 or Send an email tosales@reportsandreports.com with your contact details and questions if any. ReportsnReports.com / Contact sales@reportsandreports.com 5